Close Menu

NEW YORK (GenomeWeb) – Castle Bioscience said today that it has received a clinical laboratory permit from the New York State Department of Health, allowing the company to offer three of its PCR-based expression profile cancer tests in the state.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.